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LETTERS TO THE EDITOR
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iRegarding “Outcomes of carotid artery stenting
versus historical surgical controls for
radiation-induced carotid stenosis”
We read with interest the peri-operative results of Tallarita et
al1 with regards to intervention in asymptomatic postradiotherapy
carotid artery stenosis (CAS).
Any intervention in asymptomatic postradiotherapy CAS is, as
the authors acknowledge, controversial. We note that 47% of
patients in the study were asymptomatic.1 The indication for
surgery or stenting for CAS, whether symptomatic or asymptom-
atic, is based upon the intervention reducing long-term risk of
stroke compared with best medical therapy. In addition, proce-
dural risks must be suitably low for intervention to be justified.
In asymptomatic patients, the Asymptomatic Carotid Athero-
sclerosis Study2 and the Asymptomatic Carotid Surgery Trial3,4
studies demonstrated that the benefit of carotid endarterectomy in
asymptomatic patients is mainly dependent upon patient life ex-
pectancy.
In patients who have had neck radiotherapy, cancer-related
deaths need to be considered, resulting in a lower likelihood that a
patient will survive for long enough to benefit from their carotid
intervention. For example, 57% of patients in this study1 had
laryngeal or nasopharyngeal cancer. Absolute 5-year period sur-
vival is 60.6% and 61.5%, respectively.5,6 Relative to the healthy
American population, 5-year survival rates for regional and local-
ized laryngeal cancer are 41.6% and 76.7%, respectively.5 For
nasopharyngeal cancer, it is 55.7% and 82.3%, respectively.6 In
essence, these patients are far less likely to survive to 5 years to
benefit from carotid intervention because of cancer-specific death.
In the study by Tallarita and colleagues, the main cause of late
death (median, 58 months) across both groups was malignancy,
responsible for the death of approximately 30% of patients in the
CAS group and 16% of patients in the surgery group.1 This is
particularly important in the patients selected for CAS, where the
5-year survival was reported as 40%  9%.
Therefore, clinicians should be aware of these statistics
when considering surgery or stenting in the context of asymp-
tomatic carotid stenosis postradiotherapy. Assessment of a pa-
tient’s life expectancy based on the type and stage of cancer5,6 in
conjunction with an oncologist is essential. If it is deemed that
intervention is suitable given the individual patient’s prognosis,
it is then that the question of which intervention is appropriate
should be raised.
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Important observations were raised regarding the indication
f carotid interventions in asymptomatic patients with radiation-
nduced carotid stenosis (RICS). In our study, 5-year patient
urvival was 100% for open surgery and only 40% 9% for carotid
rtery stenting (CAS), mostly due to recurrent cancer, indicating
ifferences in patient selection with more liberal use of CAS in the
ast few years.1 Indeed, malignancy accounted for 13 of the 14 late
eaths (93%) in the entire cohort, while only one patient (7%) died
f stroke. There were no peri-procedural deaths, and early neuro-
ogical events occurred in 3% of open surgical and 6% of CAS
atients. Freedom from any neurologic events at 5 years was 100%
or open surgery and 90%  7% for CAS (P  .06). While these
esults indicate high risk of cancer-related death among RICS
atients treated by CAS, it also shows that both methods of carotid
evascularization were performed with no mortality, and with low
isk of peri-procedural events, albeit with a trend towards improved
troke protection for open surgery.
The natural history of asymptomatic RICS is not well
efined. However, Dorresteijn and colleagues2 indicated that
% of 367 patients treated by head and neck irradiation for
ancer developed stroke over 7 years, whereas the expected
troke rate is only 0.6% in the general population during the
ame period. In addition, the authors have not analyzed
hether patients had evidence of RICS, indicating that stroke
ates may be even higher in the subset of patients who have high
rade radiation-induced lesions.
The key questions are whether carotid revascularization
hould be indicated in any patient with asymptomatic RICS,
otably a higher risk group for neurological events and for death,
nd whether carotid revascularization is effective in preventing
trokes in these patients. Cheng and associates3 reported that
arotid stenosis progress more rapidly and more significantly in
adiated arteries compared with nonradiated arteries. In that study,
nnual progression rates were 15% for radiated and 5% for nonra-
iated arteries. At a mean follow up of 3 years, 43% of patients with
adiated arteries had progressed to stenoses 50%. The results of
he Asymptomatic Carotid Atherosclerosis Study4 and Asymptom-
tic Carotid Surgery Trial5 studies apply primarily to good risk
atients with nonradiated lesions, and not necessarily to patients
ith RICS. Nevertheless, the observations raised are of paramount
mportance on the decision-making of whether to proceed with
arotid intervention in any patient with RICS, recognizing the
everal of these patients may have limited life expectancy on the
